PT-14110mg
$50.00
In stock
Choose quantity — bulk discounts
PT-141 (Bremelanotide) 10mg, a melanocortin peptide studied in research settings.
PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist derived from the peptide Melanotan II. It is investigated for its interaction with central melanocortin pathways and examined for potential influences on neural signaling and behavioral response mechanisms. For research use only.
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide that functions as a non-selective agonist at melanocortin receptors, with notable activity at the MC4R subtype. Unlike its parent compound Melanotan II, PT-141 lacks the amide group and is studied for its distinct receptor-binding profile within the central nervous system.
Within research contexts, this 10mg presentation is examined for its role in modulating melanocortin-driven signaling pathways. Investigators have explored its influence on neural circuits, offering a tool for studying central receptor mechanisms and related behavioral models.
Key information and effects studied: - Investigated for its agonist activity at melanocortin receptors, particularly MC4R - Examined for effects on central nervous system signaling pathways - Studied for its interaction with neural circuits linked to motivation and arousal behaviors - Investigated as a research tool for understanding melanocortin receptor pharmacology - Examined for its distinct profile relative to related melanocortin peptides - Studied for potential influences on appetite and metabolic signaling in preclinical models
Third-party tested
Independently verified certificate of analysis · Batch CP2650G15 · Jun 30, 2026
Research use only. Not for human or veterinary consumption. Submit an order request and we'll reach out to confirm availability and pricing.
Note: vial caps are subject to change and may not be white.